IC

Ikarian Capital Portfolio holdings

AUM $773M
1-Year Est. Return 443.74%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+443.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$241M
AUM Growth
+$40.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
92
New
Increased
Reduced
Closed

Top Buys

1
+$11.8M
2
+$9.81M
3
+$7M
4
RCUS icon
Arcus Biosciences
RCUS
+$3.8M
5
BTAI icon
BioXcel Therapeutics
BTAI
+$3.78M

Top Sells

1
+$12.8M
2
+$5.03M
3
+$4.98M
4
SAGE
Sage Therapeutics
SAGE
+$3.44M
5
SCPH
scPharmaceuticals
SCPH
+$3.13M

Sector Composition

1 Healthcare 99.4%
2 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$31.8M 13.19%
288,926
+57,745
2
$17.2M 7.12%
966,700
+155,000
3
$12M 4.97%
+250,000
4
$11.9M 4.95%
267,476
-50,000
5
$11.8M 4.89%
1,891,147
-240,000
6
$11.6M 4.82%
+837,500
7
$10.2M 4.21%
89,219
+15,000
8
$10.1M 4.17%
675,176
-24,264
9
$8.07M 3.35%
377,021
-601,762
10
$7.51M 3.11%
737,319
-166,800
11
$7.28M 3.02%
885,334
+35,200
12
$6.67M 2.77%
255,131
-60,000
13
$6.33M 2.63%
160,486
14
$6.02M 2.5%
367,119
-125,156
15
$5.78M 2.4%
454,000
+254,000
16
$5.62M 2.33%
40,631
+17,500
17
$5.37M 2.23%
+15,625
18
$5.17M 2.15%
325,000
19
$4.9M 2.03%
+108,100
20
$4.5M 1.87%
273,432
-198,622
21
$4.44M 1.84%
62,999
-9,860
22
$4.12M 1.71%
138,277
23
$3.93M 1.63%
1,378,825
-1,800,000
24
$3.75M 1.56%
3,655
-2,059
25
$3.67M 1.52%
28,324
+11,515
1
2 3 4